Zhihong Li

Person

Millbrae, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compounds that inhibit MCL-1 protein
- Patent number 11,306,107
- Issue date Apr 19, 2022
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods for modulating adenosine A2B receptor and ade...
- Patent number 11,254,686
- Issue date Feb 22, 2022
- CORVUS PHARMACEUTICALS, INC.
- Zhihong Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that inhibit MCL-1 protein
- Patent number 10,836,779
- Issue date Nov 17, 2020
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds that inhibit Mcl-1 protein
- Patent number 10,100,063
- Issue date Oct 16, 2018
- Amgen Inc.
- Sean P. Brown
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,593,129
- Issue date Mar 14, 2017
- Amgen, Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer
- Patent number 9,376,425
- Issue date Jun 28, 2016
- Amgen, Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused tricyclic dual inhibitors of CDK 4/6 and FLT3
- Patent number 9,359,355
- Issue date Jun 7, 2016
- Amgen Inc.
- Xiaoqi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 9,296,736
- Issue date Mar 29, 2016
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyridine, pyrimidine and triazine compounds as cell cycle inh...
- Patent number 8,980,903
- Issue date Mar 17, 2015
- Amgen Inc.
- Richard V. Connors
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyridine, pyrimidine and triazine compounds as cell cycle inh...
- Patent number 8,841,312
- Issue date Sep 23, 2014
- Amgen Inc.
- Richard V. Connors
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fused tricyclic dual inhibitors of CDK 4/6 and FLT3
- Patent number 8,623,885
- Issue date Jan 7, 2014
- Amgen Inc.
- Xiaoqi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...
- Patent number 8,569,341
- Issue date Oct 29, 2013
- Amgen Inc.
- Michael Gribble
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as ce...
- Patent number 8,389,533
- Issue date Mar 5, 2013
- Amgen Inc.
- Richard V. Connors
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20240300892
- Publication date Sep 12, 2024
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20220169611
- Publication date Jun 2, 2022
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20210230189
- Publication date Jul 29, 2021
- Amgen Inc.
- Sean P. BROWN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20210179560
- Publication date Jun 17, 2021
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADE...
- Publication number 20200079793
- Publication date Mar 12, 2020
- Corvus Pharmaceuticals, Inc.
- Zhihong Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20200062780
- Publication date Feb 27, 2020
- Amgen Inc.
- Sean P. BROWN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20190062276
- Publication date Feb 28, 2019
- Amgen Inc.
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20190023720
- Publication date Jan 24, 2019
- Amgen Inc.
- Sean P. BROWN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20190016736
- Publication date Jan 17, 2019
- Amgen Inc.
- Sean P. BROWN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROP...
- Publication number 20180087079
- Publication date Mar 29, 2018
- Amgen Inc.
- Zhimei DU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20170144971
- Publication date May 25, 2017
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20170088560
- Publication date Mar 30, 2017
- Amgen Inc.
- Sean P. BROWN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED TRICYCLIC DUAL INHIBITORS OF CDK 4/6 AND FLT3
- Publication number 20160368933
- Publication date Dec 22, 2016
- Amgen Inc.
- Xiaoqi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...
- Publication number 20160137667
- Publication date May 19, 2016
- Amgen Inc.
- Michael D. BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS THAT INHIBIT MCL-1 PROTEIN
- Publication number 20160068545
- Publication date Mar 10, 2016
- Amgen Inc.
- Sean P. BROWN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROP...
- Publication number 20150353542
- Publication date Dec 10, 2015
- Amgen Inc.
- Zhimei DU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED PYRIDINE, PYRIMIDINE AND TRIAZINE COMPOUNDS AS CELL CYCLE INH...
- Publication number 20140350244
- Publication date Nov 27, 2014
- Richard V. Connors
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20140315895
- Publication date Oct 23, 2014
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER
- Publication number 20140235629
- Publication date Aug 21, 2014
- Michael D. Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROP...
- Publication number 20140199728
- Publication date Jul 17, 2014
- Amgen Inc.
- Zhimei DU
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
FUSED TRICYCLIC DUAL INHIBITORS OF CDK 4/6 AND FLT3
- Publication number 20140163052
- Publication date Jun 12, 2014
- Amgen Inc.
- Xiaoqi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20140011796
- Publication date Jan 9, 2014
- Amgen Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSED TRICYCLIC DUAL INHIBITORS OF CDK 4/6 AND FLT3
- Publication number 20120244110
- Publication date Sep 27, 2012
- Amgen Inc.
- Xiaoqi Chen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...
- Publication number 20110319378
- Publication date Dec 29, 2011
- Amgen Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inh...
- Publication number 20110142796
- Publication date Jun 16, 2011
- Amgen Inc.
- Richard V. Connors
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Gem-Disubstituted and Spirocyclic Amino Pyridines/Pyrimidines as Ce...
- Publication number 20110097305
- Publication date Apr 28, 2011
- Amgen Inc.
- Richard V. Connors
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ALKYNYL ALCOHOLS AS KINASE INHIBITORS
- Publication number 20110086834
- Publication date Apr 14, 2011
- Amgen Inc.
- Guoqing Chen
- C07 - ORGANIC CHEMISTRY

Person

Patents Grantslast 30 patents

Compounds that inhibit MCL-1 protein

Compounds and methods for modulating adenosine A2B receptor and ade...

Compounds that inhibit MCL-1 protein

Compounds that inhibit Mcl-1 protein

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Heterocyclic compounds as MDM2 inhibitors for the treatment of cancer

Fused tricyclic dual inhibitors of CDK 4/6 and FLT3

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Fused pyridine, pyrimidine and triazine compounds as cell cycle inh...

Fused pyridine, pyrimidine and triazine compounds as cell cycle inh...

Fused tricyclic dual inhibitors of CDK 4/6 and FLT3

Piperidinone derivatives as MDM2 inhibitors for the treatment of ca...

Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as ce...

Patents Applicationslast 30 patents

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

COMPOUNDS AND METHODS FOR MODULATING ADENOSINE A2B RECEPTOR AND ADE...

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROP...

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

FUSED TRICYCLIC DUAL INHIBITORS OF CDK 4/6 AND FLT3

Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Ca...

COMPOUNDS THAT INHIBIT MCL-1 PROTEIN

METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROP...

FUSED PYRIDINE, PYRIMIDINE AND TRIAZINE COMPOUNDS AS CELL CYCLE INH...

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

HETEROCYCLIC COMPOUNDS AS MDM2 INHIBITORS FOR THE TREATMENT OF CANCER

METHODS OF USING CELL-CYCLE INHIBITORS TO MODULATE ONE OR MORE PROP...

FUSED TRICYCLIC DUAL INHIBITORS OF CDK 4/6 AND FLT3

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

FUSED TRICYCLIC DUAL INHIBITORS OF CDK 4/6 AND FLT3

PIPERIDINONE DERIVATIVES AS MDM2 INHIBITORS FOR THE TREATMENT OF CA...

Fused Pyridine, Pyrimidine and Triazine Compounds as Cell Cycle Inh...

Gem-Disubstituted and Spirocyclic Amino Pyridines/Pyrimidines as Ce...

ALKYNYL ALCOHOLS AS KINASE INHIBITORS